Yeda Research and Development Company Ltd. is the commercial arm of the Weizmann Institute of Science. Yeda holds an exclusive agreement with the Weizmann Institute to commercialize the unique intellectual property developed by the scientists.
View this resource Bookmark this resourcePublic
C.H.I.CO. Cluster of Health Innovation and Community, Cluster of regione Lazio in Italy, Private organization to help Life Science Actors
View this resource Bookmark this resource
Regione Sicilia
Published by REGIONE SICILIA
Basic ResearchClinical ResearchPreclinical ResearchPublicThe OP ERDF Sicily 2014/2020 was built on the basis of an analysis of the relevant needs, problems and opportunities that characterize the Sicilian Region with the involvement of the territory through a path of public consultation. The thematic objectives and investment priorities have been identified on the basis of EU Regulations n. 1301/2013 and n. 1303/2013 and the Partnership Agreement for Italy 2014/2020.
View this resource Bookmark this resource
InnovFin – ‘EU Finance for Innovators’
Published by EIB
Clinical ResearchIndustrial Development or SMEPreclinical ResearchPublicA joint initiative launched by the European Investment Bank Group (EIB) in cooperation with the European Commission under Horizon 2020
View this resource Bookmark this resource
BRIDGE HEAD
Published by EIT
Clinical ResearchIndustrial Development or SMEPreclinical ResearchPublicThis is an internationalisation programme for start-ups interested in being hosted by one or more top-notch Accelerators or Incubators/clusters from the EIT Health European network. Start-ups travel to accelerators of their choice to speed up access to markets, tap into local networks of partners and clients, access infrastructure and get a first-hand feeling for the local regulatory and business context.
View this resource Bookmark this resource
Tool 1: The Importance of Public Private Partnerships in Rare Diseas
Published by
European Reference NetworkIndustry collaborationPrivatePublicRare DiseaseResearch and Drug DevelopmentThis resource explains the importance of public-private partnerships or collaborations for the rare disease community, in the light of the needs of the rare disease field and the current climate around research and innovation
View this resource Bookmark this resourceThe Playbook provides a practical, user-friendly guide to navigating the complexities of data sharing in IMI/IHI collaborative health research projects, outlining key concepts, roles, decision points, common challenges, and strategies to address legal, technical, and organisational obstacles. It encourages early planning, stakeholder engagement, and adoption of standardised best practices to accelerate data sharing and improve research efficiency across multi-partner consortia
View this resource Bookmark this resourceUKRI Medical Research Country invests in research on behalf of the UK tax payer. The research has resulted in life-changing discoveries for over a hundred years. Scientists apply to the MRC for funding for their research and applications are reviewed by panels of independent experts.
View this resource Bookmark this resourceThe ERC, set up by the European Union in 2007, is the premier European funding organisation for excellent frontier research. It funds creative researchers of any nationality and age, to run projects based across Europe. ERC complements other funding activities in Europe such as those of the national research funding agencies, and is a flagship component of Horizon 2020, the European Union’s Research Framework Programme for 2014 to 2020.
View this resource Bookmark this resource